DHA-enriched fish oil reduced sCD163 levels in T2DM patients.
Waist, WHtR, and serum TG levels were reduced by fish oil supplementation.
Serum ADMA level significantly reduced in fish oil group during study period.
Between-group changes in ADMA levels didn't show significant differences.
Short-term fish oil supplementation couldn't modify insulin resistance.